Detailed information for compound 1523335

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 500.653 | Formula: C26H36N4O4S
  • H donors: 1 H acceptors: 3 LogP: 2.56 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 2
  • SMILES: COc1ccc(c(c1C)C)S(=O)(=O)N1CC(c2c1cccc2)C(=O)NCCCN1CCN(CC1)C
  • InChi: 1S/C26H36N4O4S/c1-19-20(2)25(11-10-24(19)34-4)35(32,33)30-18-22(21-8-5-6-9-23(21)30)26(31)27-12-7-13-29-16-14-28(3)15-17-29/h5-6,8-11,22H,7,12-18H2,1-4H3,(H,27,31)
  • InChiKey: NKYZPXWNGDIHCJ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens arginine vasopressin receptor 1B Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0052 0.0109 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0052 0.0109 1
Mycobacterium ulcerans UDP-N-acetylglucosamine 1-carboxyvinyltransferase 0.1286 1 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0052 0.0109 1
Mycobacterium leprae PROBABLE UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE MURA 0.0923 0.7094 1
Toxoplasma gondii shikimate dehydrogenase substrate binding domain-containing protein 0.0362 0.2599 1
Mycobacterium ulcerans 3-phosphoshikimate 1-carboxyvinyltransferase 0.0362 0.2599 0.2599
Leishmania major hypothetical protein, conserved 0.0038 0 0.5
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0052 0.0109 1
Mycobacterium tuberculosis Possible penicillin-binding protein 0.0245 0.1654 0.2331
Treponema pallidum UDP-N-acetylglucosamine 1-carboxyvinyltransferase 0.1286 1 0.5
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0052 0.0109 1
Trichomonas vaginalis D-aminoacylase, putative 0.0038 0 0.5
Onchocerca volvulus 0.0038 0 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.0038 0 0.5
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0052 0.0109 1
Trichomonas vaginalis penicillin-binding protein, putative 0.0038 0 0.5
Trichomonas vaginalis esterase, putative 0.0038 0 0.5
Wolbachia endosymbiont of Brugia malayi UDP-N-acetylglucosamine 1-carboxyvinyltransferase 0.1286 1 0.5
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0052 0.0109 1
Mycobacterium tuberculosis Probable UDP-N-acetylglucosamine 1-carboxyvinyltransferase MurA 0.0923 0.7094 1
Trichomonas vaginalis D-aminoacylase, putative 0.0038 0 0.5
Trichomonas vaginalis penicillin-binding protein, putative 0.0038 0 0.5
Onchocerca volvulus 0.0038 0 0.5
Onchocerca volvulus 0.0038 0 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.0038 0 0.5
Mycobacterium leprae probable 3-phosphoshikimate 1-carboxyvinyl transferase AroA (5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE) (EPSP SYNTHASE) (EPSPS 0.0362 0.2599 0.3663
Trypanosoma brucei hypothetical protein, conserved 0.0038 0 0.5
Plasmodium vivax hypothetical protein, conserved 0.0038 0 0.5
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0052 0.0109 1
Trichomonas vaginalis D-aminoacylase, putative 0.0038 0 0.5
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0052 0.0109 1

Activities

Activity type Activity value Assay description Source Reference
Activity (binding) Binding affinity to 5HT6 receptor ChEMBL. 21601454
Ki (binding) = 1.2 uM Displacement of [3H]-AVP from human vasopressin V1B receptor expressed in CHO cells ChEMBL. 21601454

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.